Terug
Dagbereik
€ 27,67
€ 28,68
52-Weeksbereik
€ 25,17
€ 36,32
Volume
2.131.543
50D / 200D Gem.
€ 31,35
/
€ 29,72
Vorige Slotkoers
€ 28,15
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 19,1 | 0,4 |
| P/B | 2,5 | 2,9 |
| ROE % | 14,7 | 3,8 |
| Net Margin % | 16,4 | 3,9 |
| Rev Growth 5Y % | 5,9 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 46,83
+69.0%
Low: € 43,00
High: € 56,00
Forward WPA
-€ 0,31
Omzet Sch.
1,8 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,17
€ 3,06 – € 3,39
|
2,5 B | 4 |
| FY2029 |
€ 2,18
€ 2,10 – € 2,33
|
2,3 B | 4 |
| FY2028 |
€ 1,45
-€ 0,26 – € 3,89
|
2 B | 10 |
Belangrijkste Punten
Revenue grew 5,89% annually over 5 years — modest growth
Earnings declined -34,16% over the past year
ROE of 14,72% — decent returns on equity
Net margin of 16,37% shows strong profitability
Debt/Equity of 0,04 — conservative balance sheet
Generating 480,33M in free cash flow
Groei
Revenue Growth (5Y)
5,89%
Revenue (1Y)-5,25%
Earnings (1Y)-34,16%
FCF Growth (3Y)16,60%
Kwaliteit
Return on Equity
14,72%
ROIC10,08%
Net Margin16,37%
Op. Margin17,21%
Veiligheid
Debt / Equity
0,04
Current Ratio3,55
Interest Coverage20,69
Waardering
P/E Ratio
19,11
P/B Ratio2,54
EV/EBITDA14,05
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5,25% | Revenue Growth (3Y) | -5,80% |
| Earnings Growth (1Y) | -34,16% | Earnings Growth (3Y) | -17,58% |
| Revenue Growth (5Y) | 5,89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,48B | Net Income (TTM) | 241,66M |
| ROE | 14,72% | ROA | 9,55% |
| Gross Margin | 86,31% | Operating Margin | 17,21% |
| Net Margin | 16,37% | Free Cash Flow (TTM) | 480,33M |
| ROIC | 10,08% | FCF Growth (3Y) | 16,60% |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 3,55 |
| Interest Coverage | 20,69 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 19,11 | P/B Ratio | 2,54 |
| P/S Ratio | 3,13 | PEG Ratio | -0,56 |
| EV/EBITDA | 14,05 | Dividend Yield | 0,00% |
| Market Cap | 4,62B | Enterprise Value | 3,57B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,48B | 1,56B | 1,66B | 1,11B | 1,17B |
| Net Income | 241,66M | 367,07M | 355,76M | -158,27M | -48,17M |
| EPS (Diluted) | 1,43 | 2,17 | 2,10 | -0,97 | -0,30 |
| Gross Profit | 1,27B | 1,31B | 1,41B | 893,73M | 976,43M |
| Operating Income | 253,96M | 420,64M | 414,12M | -6,09M | 97,75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,53B | 2,06B | 2,14B | 1,96B | 2,02B |
| Total Liabilities | 710,96M | 590,59M | 933,54M | 920,23M | 911,90M |
| Shareholders' Equity | 1,82B | 1,46B | 1,20B | 1,04B | 1,11B |
| Total Debt | 70,00M | 75,54M | 372,19M | 379,44M | 416,21M |
| Cash & Equivalents | 1,12B | 291,15M | 457,47M | 292,47M | 337,54M |
| Current Assets | 1,93B | 1,42B | 1,49B | 1,13B | 1,06B |
| Current Liabilities | 543,44M | 465,20M | 520,22M | 497,74M | 471,29M |